Home Archive
Archive
2024 Volume 45 Issue 6  Published: 2024-06-10
    Topic
  • Miao LI , Yanrui GAO , Le KUAI , Bin LI , Ying ZHANG , Mi ZHOU
    doi: 10.13683/j.wph.2024.06.001

    The mutual penetration and influence between the mythological system and traditional Chinese medicine (TCM) culture have jointly formed the unique cultural heritage of TCM. In the process of compiling related prescriptions in traditional Chinese surgery, the author found that "Xian" and "Shen" formula are widely used in clinical practice. By studying the "Xian" and "Shen" culture, this paper discussed the application of representative "Xian" and "Shen" formula in medicine, explored the relationship between the concept of "Xian" and "Shen" and the development of TCM, aimed to open up new ideas for the clinical use of TCM in dermatology.

  • Topic
  • Yiting ZHAO , Haiyan ZHANG , Yajing CAO , Jiandan LI , Xidie YIN , Peiru WANG
    doi: 10.13683/j.wph.2024.06.002

    Artemisinin and its derivatives, including artemether, dihydroartemisinin, artesunate, are natural products extracted from the traditional Chinese plant Artemisia annua L.. Artemisinin and its derivatives have anti-parasitic, anti-viral, antibacterial, antifungal, anti-inflammatory, anticancer, immunomodulatory and other effects, and play an important role in inflammatory skin diseases, photoaging and skin tumors. The main mechanisms of action in the treatment of skin-related diseases include regulating immune cell function, reducing the level of inflammatory factors, regulating cell signaling pathways, and inhibiting the proliferation of tumor cells. This paper described the effects of artemisinin and its derivatives on the above mentioned skin diseases in terms of therapeutic efficacy and mechanism of action, and summarized the relevant action targets and pathways, so as to provide reference for further study of its application.

  • Article
  • Hui ZHOU , Xin YANG , Xijie WANG , Jing MA
    doi: 10.13683/j.wph.2024.06.003
    Objective

    To investigate the potential of circulating microRNA (miR)-124 as a marker of motor neurotoxicity of aconitine.

    Method

    Forty-two rats were randomly divided into control group, aconitine 0.025 mg/kg (low dose) group and aconitine 0.05 mg/kg (high dose) group, 14 rats in each group, and were given intravenous injection for 14 days. Functional observation combination was used to detect the change of motor behavior. The pathology of brain tissue was observed. The apoptosis of brain cells was detected. Real-time fluorescence quantitative polymerase chain reaction was used to detect the expression of miR-124 in brain and blood. The levels of neuron-specific enolase (NSE) and glial fibrillary acidic protein (GFAP) in blood were detected by enzyme-linked immunosorbent assay.

    Results

    Compared with the control group, the motor behavior of D14 in low dose group and D1 and D14 in high dose group showed easier cage movement, reduced head or body movement, and weakened reflexes after administration (P<0.05). Brain striatum necrosis and glial cell dysplasia were observed in high dose group. The apoptosis of cerebellar granule cell layer and cerebral cortex was increased in low dose and high dose groups, and the expression level of miR-124 in brain tissue was increased (P<0.01). The increase of circulating miR-124 was the earliest in high dose group at 1 h after D1 administration (P<0.01). At 8 h after D1 administration, the increase of circulating NSE and GFAP in high dose group was the earliest (P<0.01).

    Conclusion

    Compared with circulating NSE and GFAP, circulating miR-124 increased earlier in high dose group, which has the potential to detect the motor neurotoxicity of aconitine.

  • Article
  • Liping ZHAO , Qing SUN , Guirong WANG
    doi: 10.13683/j.wph.2024.06.004
    Objective

    To explore the mechanism of Zhonghe decoction in the intervention of abscess type lymph node tuberculosis.

    Methods

    Cell counting Kit 8 method was used to detect the cytotoxicity of THP-1 in different concentrations of neutralization soup solution. The results were further sequenced by second-generation high-throughput RNA transcriptome sequencing technology, and the differentially expressed genes were screened, and the Gene Ontology functional annotation and pathway analysis of Kyoto Encyclopedia of Genes and Genomes were performed.

    Results

    Zhonghe decoction can reduce the expression of inflammatory factors, inhibit the pathway related to bacterial infection, reduce the response of phosphatidylinositol 3-kinase/protein kinase B signaling pathway, and inhibit the signaling pathway related to pyroptosis and autophagy.

    Conclusion

    Zhonghe decoction may interfere with lymph node tuberculosis by inhibiting cell pyrodeath by inhibiting phosphatidylinositol 3-kinase/protein kinase B signaling pathway.

  • Article
  • Shuchun LI , Li ZHOU , Lingyan ZHU , Qiong WU , Chenyang LIU , Min CAO
    doi: 10.13683/j.wph.2024.06.005
    Objective

    To investigate the effect of Zhenxin prescription on cardiac function in rats with abdominal aortic coarctation and heart failure (HF).

    Method

    Forty Wistar rats were randomly divided into sham operation group, model group, Zhenxin prescription group and bisoprolol group, with 10 rats in each group. Except the sham operation group, the other groups of rats were treated with abdominal aortic coarctation to establish the HF rat model. Zhenxin prescription group was given 5.6 g/kg/d of Zhenxin prescription suspension, bisoprolol group was given 1 mg/kg/d of bisoprolol fumarate suspension, sham operation group and model group were given the same amount of normal saline intragastric administration for 12 weeks. The contents of echocardiography, left ventricular mass index (LVMI), brain natriuretic peptide (BNP), aldosterone (ALD), angiotensin (Ang) Ⅱ, lactic acid, pyruvic and free fatty acid in all groups were compared.

    Results

    Compared with sham operation group, the serum contents of BNP, ALD, AngⅡ, lactic acid, pyruvate and free fatty acid in model group were significantly increased (P<0.01). Compared with model group, Zhenxin prescription could increase left ventricular ejection fraction, improve myocardial tissue lesion, myocardial fibrosis and LVMI, and significantly decrease serum BNP, ALD, AngⅡ, pyruvate and free fatty acid (P<0.01).

    Conclusion

    Zhenxin prescription can effectively regulate heart function and improve ventricular remodeling in rats with HF, which may be related to reducing the accumulation of serum metabolites.

  • Article
  • Qiaohui CHEN , Dezhi CHEN , Yanyu XU , Shenglu LIN , Renpei LIANG , Jiakun WANG
    doi: 10.13683/j.wph.2024.06.006
    Objective

    To investigate the effect of shikonin on cyclic adenosine monophosphate (cAMP)/protein kinase (PK) A/cAMP response element binding protein (CREB) signaling pathway on multiple myeloma cells.

    Methods

    The logarithmically grown RPMI-8226 cells were divided into A (blank) group, B (250 μmol/L shikonin) group, C (500 μmol/L shikonin) group, D (1 000 μmol/L) shikonin group, E (SQ22536) group and F (1 000 μmol/L shikonin+SQ22536) group. The apoptosis was observed by Hoechst 33324 staining and flow cytometry. Cell counting kit (CCK)-8 was used to detect cell proliferation. The level of cAMP was detected by enzyme linked immunosorbent assay (ELISA). The expression levels of pathway-related proteins, cyclin D1 and cleaved caspase-3 were detected by western blot.

    Results

    Compared with group A, the proliferation rate and cyclin D1 expression of RPMI-8226 cells in group E were significantly increased, and the apoptosis rate, cAMP level, cleaved caspase-3, p-PKA/PKA, and p-CREB/CREB expressions were significantly decreased (P<0.05). However, cell proliferation rate and cyclin D1 expression were significantly decreased in groups B, C and D, and apoptosis rate, cAMP level, cleaved caspase-3, p-PKA/PKA, and p-CREB/CREB expression were significantly increased, with statistical differences among different concentrations (P<0.05). Compared with group E, cell proliferation rate and cyclin D1 expression in group F were significantly decreased, apoptosis rate, cAMP level, cleaved caspase-3, p-PKA/PKA, and p-CREB/CREB expression were significantly increased in group F (P<0.05). Compared with group D, cell proliferation rate and cyclin D1 expression in group F were significantly increased, apoptosis rate, cAMP level, cleaved caspase-3, p-PKA/PKA, and p-CREB/CREB expression were significantly decreased (P<0.05).

    Conclusion

    Shikonin inhibits the cell proliferation and promote apoptosis of MM cells by regulating the cAMP/PKA/CREB signaling pathway.

  • Article
  • Suping ZHOU , Zhiyong WU , Jinshun LI , Xu ZHONG
    doi: 10.13683/j.wph.2024.06.007
    Objective

    To investigate the efficacy of sequential administration of sacubitril valsartan and enalapril in the treatment of chronic heart failure (CHF).

    Methods

    A total of 112 CHF patients were randomly divided into the observation group (sequential administration of sacubitril valsartan and enalapril) and the control group (enalapril), with 56 cases in each group. The efficacy, cardiac function, myocardial enzyme spectrum index, serum myeloid differentiation factor (MyD)88, microRNA (miR)-30a, miR-101a, and quality of life were compared between the two groups before and 6 months after treatment.

    Results

    After treatment, the total effective rate in the observation group was higher than that in the control group (96.43% vs 83.93%, P<0.05). Left ventricular end-diastolic diameter, left ventricular end-systolic diameter, creatine kinase, creatine kinase isoenzyme, hydroxybutyrate dehydrogenase, cardiac troponin, N-terminal brain natriuretic peptide, MyD88, miR-30a and score of Minnesota Living with HF Questionnaire were lower than before treatment in the both groups, and the observation group was lower than the control group (P<0.05). Left ventricular ejection fraction, 6 minutes walking distance and miR-101a were higher than before treatment in both groups, and the observation group was higher than control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (12.50% vs 8.93%, P>0.05).

    Conclusion

    Sequential administration of sacubitril valsartan and enalapril is safe and effective in the treatment of CHF, promoting the improvement of cardiac function and quality of life of patients.

  • Article
  • Zhongjian LI , Qianqian LIU , Zhen LIU , Zhibing WANG
    doi: 10.13683/j.wph.2024.06.008
    Objective

    To investigate the curative effect of Liangge powder modified prescription on acute respiratory distress syndrome (ARDS) caused by sepsis.

    Methods

    Eighty patients with ARDS caused by sepsis were randomly divided into control group (ulinastatin treatment) and experimental group (Liangge powder modified prescription combined with ulinastatin treatment). The arterial carbon dioxide pressure (PaCO2) and partial pressure of oxygen (PaO2), oxygenation index (PaO2/FiO2), C-reactive protein (CRP), interleukin (IL)-6, tumor necrosis factor (TNF)-α, extravascular lung water index (EVLWI), pulmonary vascular permeability index (PVPI), prognosis and safety were compared between the two groups before and after treatment.

    Results

    After treatment, the total effective rate of experimental group was higher than that of control group (P<0.05). PaO2 and PaO2/FiO2 in the experimental group were higher than before treatment and the control group (P<0.05). The PaCO2, serum CRP, IL-6, TNF-α, EVLWI and PVPI in the experimental group were lower than those of the control group (P<0.05). The mechanical ventilation time and ICU stay time of the experimental group were shorter than those of the control group (P<0.05). The mortality rate of 28 d, acute physiology and chronic health evaluation II and sequential organ failure assessment score after treatment were lower than those of control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).

    Conclusion

    Liangge powder modified prescription combined with ulinastatin in the treatment of ARDS caused by sepsis can effectively improve the respiratory function of patients, reduce inflammation, correct hypoxemia, shorten mechanical ventilation and hospital stay, reduce mortality, improve prognosis, and have good safety.

  • Article
  • Yanling QIN , Qiannan LI , Yachai WANG , Qingyi WANG
    doi: 10.13683/j.wph.2024.06.009
    Objective

    To investigate the therapeutic effect of Qingre Jiedu formula combined with desonide cream in the treatment of psoriasis with heat toxin incandescent syndrome and its impacts on inflammatory factors and peripheral blood T lymphocyte subsets.

    Methods

    A total of 96 patients who underwent treatment for psoriasis with heat toxin incandescent syndrome in our hospital from July 2022 to May 2023 were grouped into the experimental group (n=48) and the control group (n=48) by random number table method. The control group was treated with desonide cream, and the experimental group was treated with Qingre Jiedu formula prescription on the basis of the control group. The psoriasis area and severity index (PASI) score, traditional Chinese medicine (TCM) syndrome score, efficacy, serum inflammatory factor levels, T lymphocyte subsets levels, and adverse reactions were compared between the two groups.

    Results

    The total effective rate of the experimental group was higher than that of the control group (79.17% vs 39.58%, P<0.05). After treatment, the PASI, TCM syndrome score, interleukin (IL)-6, tumor necrosis factor-α, nerve growth factor, vascular endothelial growth factor, CD3+, CD4+, and CD4+/CD8+ of both group were reduced compared with those before treatment, and the experimental group was lower than the control group (P<0.05). The IL-10, transforming growth factor-β1, and CD8+ of both group were increased, and those of the experimental group were higher than those of the control group (P<0.05). There was no statistical difference in the incidence of adverse reactions between the two groups (P>0.05).

    Conclusion

    Qingre Jiedu formula prescription combined with desonide cream has a high therapeutic effect on psoriasis with heat toxin incandescent syndrome, and can improve immunity of patients by regulating inflammatory factors and T lymphocyte subsets, with good safety.

  • Article
  • Min FU , Dong BO , Li DUAN
    doi: 10.13683/j.wph.2024.06.010
    Objective

    To investigate the curative effect of compound Eucommia ulmoides decoction combined with hydroxychloroquine on rheumatoid arthritis (RA).

    Methods

    A total of 98 RA patients admitted to our hospital from July 2020 to October 2022 were randomly divided into control group (hydroxychloroquine) and observation group (hydroxychloroquine+compound Eucommia ulmoides decoction), with 49 patients in each group. The effective rate, disease activity score in 28 joints (DAS28), rheumatoid factor (RF) and C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), disease activity, serum interferon regulatory factor (IRF)4 level, morning stiffness and average grip strength were compared between the two groups after treatment.

    Results

    After treatment, the total effective rate of observation group was higher than that of control group (91.84% vs 71.43%)(P<0.05). The levels of DAS28, IRF4, RF, CRP, ESR, morning stiffness time, joint swelling number and joint tenderness number in both groups were reduced, and the reduction was more significant in observation group than that in control group (P<0.05). The average hand grip strength of both groups was higher than before, and the observation group was higher than that in control group (P<0.05).

    Conclusion

    Compound Eucommia ulmoides decoction combined with hydroxychloroquine can effectively reduce disease activity and improve clinical symptoms in RA patients.

  • Article
  • Huimin CAO , Haidong FANG , Yushan CHEN
    doi: 10.13683/j.wph.2024.06.011
    Objective

    To explore the effect of roxadustat on renal anemia (RA) patients with low responsiveness to erythropoietic stimulant (ESA) receiving maintenance hemodialysis (MHD), and its effects on serum hemoglobin (Hb) compliance rate and folic acid (FA) level.

    Methods

    A total of 100 RA patients with low responsiveness to ESA receiving MHD in the department of nephrology in our hospital were selected and randomly divided into recombinant human erythropoietin (rhEPO) group and roxadustat group, 50 cases in each group. The two groups were treated continuously for 12 weeks, and the Hb compliance rate and serum FA level were compared between the two groups after treatment.

    Results

    At 4 and 12 weeks of treatment, the Hb compliance rate in roxadustat group was higher than that in rhEPO group (P<0.05). After treatment, serum Hb, FA, hematocrit, erythrocyte count and vitamin B12 levels in roxadustat group were higher than those in rhEPO group (P<0.05), serum ferritin, transferrin saturation and serum iron level in roxadustat group were lower than those in rhEPO group (P<0.05).

    Conclusion

    Roxadustat has significant efficacy in RA patients with low responsiveness to ESA receiving MHD, which can effectively improve anemia status, increase Hb compliance rate and serum FA level, improve iron metabolism, and has good safety.

  • Article
  • Jiayuan WANG , Hua YANG , Tengfei WU , Yilei CONG , Bowen LIU
    doi: 10.13683/j.wph.2024.06.012
    Objective

    To observe the effect of combination of Qiyu prescription and vitamin D on Hashimoto's thyroiditis (HT) of Qi deficiency and liver depression syndrome.

    Methods

    A total of 113 HT patients with Qi deficiency and liver depression syndrome in department of endocrinology of our hospital from March to December 2023 were included and randomly divided into traditional Chinese medicine (TCM) group (n=38, basic treatment+Qiyu prescription), TCM+vitamin D group (n=38, basic treatment+Qiyu prescription+alfacalcidol) and control group (n=37, basic treatment). All patients were treated for 12 weeks. Thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb), thyroid-stimulating hormone (TSH) levels and TCM syndrome scores of three groups were observed before and after treatment.

    Results

    The clinical effective rates of TCM group and TCM+vitamin D group were 78.95% and 84.21%, which were higher than control group (40.54%)(P<0.05). The titers of thyroid autoantibody in TCM group and TCM+vitamin D group were lower than before treatment (P<0.05), and the change rates of antibody were better than that in control group, and the change rates of TPOAb in TCM+vitamin D group were better than that in TCM group (P<0.05). TCM syndrome scores in TCM group and TCM+vitamin D group were lower than before treatment (P<0.05), and better than control group (P<0.05).

    Conclusion

    Combination of Qiyu prescription and vitamin D has a better effect on HT patients with Qi deficiency and liver depression syndrome, and can reduce serum TPOAb and TgAb levels, which is more effective on TPOAb compared to the use of TCM alone.

  • Article
  • Sa PAN , Lei XIAO , Hua WANG
    doi: 10.13683/j.wph.2024.06.013
    Objective

    To investigate the effects of combination of Wenshen Huatan Tiaojing prescription and conventional western medicine on reproductive hormone, glycolipid metabolism in patients with polycystic ovary syndrome (PCOS) of kidney deficiency phlegm-dampness.

    Methods

    A total of 96 PCOS patients of kidney deficiency and phlegm-dampness admitted to our hospital from January 2022 to January 2023 were randomly divided into observation group (ethoestradiol cyproterone+metformin+Wenshen Huatan Tiaojing prescription) and control group (ethoestradiol cyproterone+metformin) according to simple sort, with 48 cases in each group. The treatment lasted for 21 days and drug withdrawal for 7 days. Both groups were treated for 3 consecutive courses. The clinical efficacy, luteinizing hormone (LH), LH/follicular estrogen (FSH), anti-muller test tube hormone (AMH), inhibin (INH)B, glycosylated hemoglobin (Hb) A1c, total cholesterol (TC), triacylglycerol (TG) and homeostasis model assessment-insulin resistance (HOMA-IR) were compared between the two groups.

    Results

    The total effective rate of the observation group was higher than that of the control group (89.58% vs 62.50%, P<0.05). The levels of LH and LH/FSH in the observation group were lower than those in the control group (P<0.05). The levels of AMH, INHB, HbA1c, TC, TG and HOMA-IR in observation group were lower than those in control group (P<0.05). There was no significant difference in adverse reactions between the two groups (P>0.05).

    Conclusion

    Combination of Wenshen Huatan Tiaojing prescription and conventional western medicine has obvious effect on PCOS patients of kidney deficiency phlegm-dampness, which can help regulate reproductive hormone and glycolipid metabolism indexes.

  • Article
  • Jian ZHAO , Juping BAI , Yunhua WEI , Yanbin GAO
    doi: 10.13683/j.wph.2024.06.014
    Objective

    To observe the clinical effect of Jianpi Lishui Huazhuo prescription in the treatment of overweight or obesity complicated with hyperuricemia (HUA).

    Methods

    A total of 90 overweight or obese patients with HUA in the department of traditional Chinese medicine (TCM) of our hospital from October 2020 to June 2023 were selected and divided into treatment group and control group according to simple sort randomization, with 45 cases in each group. Both groups were given low fat, low purine diet and febuxosta, and the treatment group was given Jianpi Lishui Huazhuo prescription. The course of treatment in both groups was 12 weeks. The therapeutic effect, body mass index (BMI) and blood uric acid (UA) levels were compared between the two groups.

    Results

    After treatment, the total effective rate of TCM syndrome in the treatment group was higher than that in the control group (92.68% vs 65.12%, P<0.05). BMI and UA levels in the treatment group were lower than those in the control group (P<0.05).

    Conclusion

    Jianpi Lishui Huazhuo prescription is effective in overweight or obese patients with HUA, which is worthy of clinical promotion.

  • Review
  • Zhaotang GONG , Wurihan , Siriguleng
    doi: 10.13683/j.wph.2024.06.015

    Extracorporeal organ support (ECOS) plays a crucial role in rescuing critically ill patients, however, there are adverse events such as bleeding and thrombosis during treatment, so selecting appropriate anticoagulants is very important in ECOS therapy. This article reviewed the anticoagulant application of heparin, low molecular weight heparin, direct thrombin inhibitors, and citric acid in extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT), elucidated the current usage status of anticoagulant drugs in ECMO and CRRT, summarized their characteristics, contraindications and associated adverse reactions, in order to provide certain theoretical basis for deeply exploring alternative options to heparin in ECMO and selecting appropriate anticoagulant drugs for high-risk bleeding patients undergoing CRRT.

  • Review
  • Juanjuan ZHANG , Hong LI , Weian MAO , Min CHEN
    doi: 10.13683/j.wph.2024.06.016

    In recent years, the incidence of gout and hyperuricemia (HUA) has been increasing year by year worldwide, which seriously affects the normal life of patients and causes great pressure on the medical and health care system. Western medicine therapy for gout and HUA is effective, but drug-related adverse reactions are difficult to ignore. Traditional Chinese medicine has gradually attracted attention because of its diversified methods and high safety. In addition, changes in microbiota, novel xanthine oxidase inhibitory peptides, and genetic markers have made more achievements in the pathogenesis, intervention and treatment of gout and HUA. This article reviewed the latest progress in the treatment of gout and HUA in recent years to provide reference for clinical reference.

  • Review
  • Jiayi CHEN , Jian SONG , Jiajian HE , Haohua XU , Huiqun LI , Encun HOU
    doi: 10.13683/j.wph.2024.06.017

    Non-small cell lung cancer (NSCLC) is a common malignant tumor in clinical practice, many patients have developed to the middle and late stages once diagnosed, and have lost the opportunity of surgical treatment. Modern medicine often uses chemoradiotherapy, targeted drugs, immune checkpoint inhibitors and other comprehensive treatment methods, but there are different degrees of adverse reactions, so that the tolerance of patients is reduced, and the 5-year survival rate of patients is still low. In recent years, the combination of traditional Chinese medicine (TCM) and western medicine has obvious advantages in the treatment of middle and advanced NSCLC, in which TCM injection plays a significant role in reducing adverse reactions in the adjuvant treatment of NSCLC. This article reviewed the research and application status of TCM injection in the adjuvant treatment of NSCLC, in order to provide reference for clinical treatment and provide ideas for the development of new preparations of TCM.

  • Pharmacy administration
  • Caiyun XIAO , Qiwei WANG , Yue LIU , Wen GUO
    doi: 10.13683/j.wph.2024.06.018

    Based on the main nodes of the pharmaceutical supply chain, including raw material production, drug production, and healthcare institution procurement, a system dynamics model was established to investigate the variations in supply at each node under different patient demand conditions. Simulation of market demand models with transition function changes, periodic function changes, and stochastic function changes was conducted to analyze the different effects on the stability of the supply chain. It is recommended that supply chain planning should flexibly adjust strategies according to demand changes to ensure the stability of drug supply and meet patient demands.

  • Pharmacy administration
  • Yiwen XU , Miao WANG , Xutao WANG , Hong SU
    doi: 10.13683/j.wph.2024.06.019
    Objective

    To investigate the impact of the national centralized procurement policies (referred to as centralized procurement below) on the use of insulin in public hospitals.

    Methods

    Using descriptive statistical analysis and interrupted time series analysis, the national implementation of insulin centralized procurement was taken as the policy intervention point to analyze the changes in sales amount, sales volume, and average daily usage cost of insulin in sample hospitals before and after the centralized procurement from 2017 Q1 (each year is divided into four quarters, which are commonly referred to as Q1, Q2, Q3, and Q4, respectively) to 2023 Q3.

    Results

    After centralized procurement, the sales trend of different types of insulin changed differently, with second-generation and foreign-funded brand insulin showing a downward trend, and third-generation and domestic brand insulin showing an upward trend. The sales amount of different types of insulin decreased, and the average daily use cost had obvious breakpoints and decreased significantly.

    Conclusion

    Centralized procurement effectively controlled the costs of insulin, promoted the iteration of insulin use, altered the brand usage landscape, and significantly reduced the drug burden of patients.

News